Replies to post #105110 on Biotech Values

[DewDiligence]

IDIX 2010-2011 News Flow

[Updated phase-2b lineup for IDX899.]


HCV

Oct 2010/AASLD: Present complete datasets from IDX184, IDX320, and IDX375 studies for which top-line data was reported in IDIX’s 9/7/10 PR (#msg-54120531).

4Q10: Start IDX375 phase-1b 3-day monotherapy trial.

Late 2010/early 2011: Possible lifting of clinical hold on IDX184 and/or IDX320 programs following FDA review of combination animal-tox study and all clinical data to date.

Late 2010: Select lead NS5A compound. Start phase-1 trial in 1H11.


HIV

4Q10: GSK enrolls first patient in phase-2b SONNET trial, which will generate a significant milestone payment for IDIX from GSK (#msg-55627169, #msg-49743057).

Early 2011: GSK start IDX899 phase-2b trial in first-line setting, testing IDX899+Truvada vs Sustiva+Truvada.